Wasdell Packaging Group has unveiled plans to build a new pharmaceutical facility in Dundalk, Ireland. The facility will be a purpose built, 70,000 sq. ft., self-contained site located at the IDA Dundalk Science and Technology Park, Mullagharlin.

Phase one of the build will occupy a 2.88 hectare site and represent an investment of more than €30 million and will create 300 jobs. Wasdell also hold the land options to expand the site further with an additional 2.68 hectares.

The facility will offer QC import testing, a variety of current and novel packaging technologies as well as storage and distribution. The site will be operational by Q4 2018 and will incorporate serialization technology in addition to bespoke customer manufacturing solutions.

The site will be Wasdell’s first outside of the UK. It will be used for import and release testing, the primary and secondary packing of drug product as well as the distribution of such products into Europe as well as internationally. The company says the facility will not only assist with its strategy of growth over the coming years but also provide a solution to a “hard” Brexit if this becomes a reality.

“We are delighted to have found such an ideal location for our new facility and a special thanks must be given to the Irish Government, the IDA as well as Louth County Council for their support in making our new site a reality,” said Martin Tedham, group managing director. “This is an exciting time for our business and will allow us to not only increase our capacity but also extend our operational footprint and the services we are able to offer our client base.”